CRL:NYSECharles River Laboratories International, Inc. Analysis
Data as of 2026-08-24 - not real-time
$294.89
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $294.89, Charles River Laboratories International, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 28.4%. With RSI at 75.9 the momentum picture is overbought, alongside a bullish MACD signal. Recent trading has carved out support near $227.38 and resistance around $299.32.
Multiples put this in fair territory: 23.2 times earnings against the sector's 31.0. The average analyst target implies 4.7% below today's level. Revenue is contracting at 2.7% on a -6.0% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 45.5%, a beta of 1.24 and a maximum drawdown of 33.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Multiples put this in fair territory: 23.2 times earnings against the sector's 31.0. The average analyst target implies 4.7% below today's level. Revenue is contracting at 2.7% on a -6.0% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 45.5%, a beta of 1.24 and a maximum drawdown of 33.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
Charles River Laboratories International Inc CRL beats Q2 targets with a 1.Charles River CRL delivered earnings and revenue surprises of +11.Lab services company Charles River Laboratories NYSE:CRL reported Q2 CY2026 results beating Wall Street’s revenue...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- RSI at 75.9 signals overbought conditions
- Trading above the 200-day average of 194.61
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- RSI at 75.9 signals overbought conditions
- P/E of 23.2 versus sector average of 31.0
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 23.2 versus sector average of 31.0
- Negative profit margin of -6.0%
- Negative return on equity of -7.5%
Key Metrics & Analysis
Financial Health
Revenue Growth-2.70%
Profit Margin-5.96%
P/E Ratio23.2
ROE-7.52%
ROA4.11%
Debt/Equity105.05
P/B Ratio5.0
Op. Cash Flow$582.1M
Free Cash Flow$468.9M
Industry P/E31.0
Technical Analysis
TrendBullish
RSI75.9
Support$227.38
Resistance$299.32
MA 20$267.16
MA 50$236.28
MA 200$194.61
MACDBullish
VolumeDecreasing
Fear & Greed Index93.11
Valuation
Fair Value$66.16
Target Price$281.00
Upside/Downside-4.71%
GradeFair
TypeBlend
Risk Assessment
Beta1.24
Volatility45.50%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.